Serological studies of West Nile virus in a liver transplant population

Canadian Journal of Infectious Diseases

Volumn 15, Issue 5, 2004, Pages 271-274

  Nicolle, L E ^a   Gutkin, A ^a   Smart, G ^b   Dawood, M ^a,b   Drebot, M ^a,c   Van Caeseele, P ^a,b   Giulivi, A ^d   Minuk, G Y ^a  

^a UNIVERSITY OF MANITOBA   (Canada)

^b CADHAM PROVINCIAL LABORATORY   (Canada)

^c PUBLIC HEALTH AGENCY OF CANADA   (Canada)

^d Lab Center for Disease Control   (Canada)

Author keywords

Liver transplant; Manitoba; West Nile virus

Indexed keywords

CYCLOSPORIN; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISONE; RAPAMYCIN; TACROLIMUS; VIRUS ANTIBODY;

ADULT; AGE; AGED; ARTICLE; BLOOD SAMPLING; CANADA; CLINICAL FEATURE; CLINICAL TRIAL; COHORT ANALYSIS; DRUG BLOOD LEVEL; DRUG DOSE REGIMEN; ENZYME IMMUNOASSAY; FEMALE; GRAFT REJECTION; HEMAGGLUTINATION INHIBITION TEST; HEPATITIS B VIRUS; HEPATITIS C VIRUS; HUMAN; IMMUNOREACTIVITY; IMMUNOSUPPRESSIVE TREATMENT; INCIDENCE; LIVER DISEASE; LIVER GRAFT; MAJOR CLINICAL STUDY; MALE; OUTPATIENT DEPARTMENT; PATIENT MONITORING; POPULATION; POSTOPERATIVE COMPLICATION; RECIPIENT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SEASON; SEROLOGY; SEX; VIRUS INFECTION; VIRUS NEUTRALIZATION; VIRUS PLAQUE; WEST NILE FLAVIVIRUS;

EID: 9344270561     PISSN: 11802332     EISSN: None     Source Type: Journal    
DOI: 10.1155/2004/606015     Document Type: Article

References (13)

1. Petersen LR, Marfin AA. West Nile virus: A primer for the clinician. Ann Intern Med 2002;137:173-9.
2. Nash D, Mostashari F, Fine A, et al. The outbreak of West Nile virus infection in the New York City area in 1999. N Engl J Med 2001;344:1807-14.
3. Pepperell C, Rau N, Krajden S, et al. West Nile virus infection in 2002: Morbidity and mortality among patients admitted to hospital in southcentral Ontario. CMAJ 2003;168:1399-405.
4. Iwamoto M, Jernigan DB, Guasch A, et al. Transmission of West Nile virus from an organ donor to four transplant recipients. N Eng J Med 2003;348:2196-203.
5. Cushing MM, Brat DJ, Mosunjae MI, et al. Fatal West Nile virus encephalitis in a renal transplant recipient. Am J Clin Pathol 2004;121:26-31.
6. Kumar D, Prasad GV, Zaltzman J, Levy GA, Humar A. Community-acquired West Nile virus infection in solid-organ transplant recipients. Transplantation 2004;77:399-402.
7. Ravindra KV, Freifeld AG, Kalil AC, et al. West Nile virus-associated encephalitis on recipients of renal and pancreas transplants: Case series and literature review. Clin Infect Dis 2004;38:1257-60.
8. Calisher CH, Karabatsos N, Dalrymple JM, et al. Antigenic relationships between flaviviruses as determined by cross-neutralization tests with polyclonal antisera. J Gen Virol 1989;70:37-43.
9. Drebot MA, Lindsay R, Barker IK, et al. West Nile virus surveillance and diagnostics: A Canadian perspective. Can J Infect Dis 2003;14:105-14.
10. Shi PY, Wong SJ. Serologic diagnosis of West Nile virus infection. Expert Rev Mol Diagn 2003;3:733-41.
11. Mostashari F, Bunning ML, Kitsutani PT, et al. Epidemic West Nile encephalitis, New York, 1999: Results of a household-based seroepidemiological survey. Lancet 2001;358:261-4.
12. Handler J, Nelson R, McCarthy T, et al. West Nile virus surveillance in Connecticut in 2000: An intense epizootic without high risk for severe human disease. Emerg Infect Dis 2001;7:636-42.
13. Cohen R, Ksiazek TG, Shemer J, Green MS. Prevalence of antibodies to West Nile fever, sandfly fever Sicilian and sandfly fever Naples viruses in healthy adults in Israel. Public Health Rev 1999;27:217-30.